IL198856A0 - Compounds useful for treating neurodegenerative disorders - Google Patents
Compounds useful for treating neurodegenerative disordersInfo
- Publication number
- IL198856A0 IL198856A0 IL198856A IL19885609A IL198856A0 IL 198856 A0 IL198856 A0 IL 198856A0 IL 198856 A IL198856 A IL 198856A IL 19885609 A IL19885609 A IL 19885609A IL 198856 A0 IL198856 A0 IL 198856A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds useful
- neurodegenerative disorders
- treating neurodegenerative
- treating
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Pest Control & Pesticides (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Environmental Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2006/044880 WO2008063165A1 (en) | 2006-11-20 | 2006-11-20 | Compounds useful for treating neurodegenerative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
IL198856A0 true IL198856A0 (en) | 2010-02-17 |
Family
ID=39429980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL198856A IL198856A0 (en) | 2006-11-20 | 2009-05-20 | Compounds useful for treating neurodegenerative disorders |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2073637A4 (en) |
JP (1) | JP2010510309A (en) |
KR (1) | KR20090087075A (en) |
CN (1) | CN101610673A (en) |
AU (1) | AU2006350960B2 (en) |
BR (1) | BRPI0622138A2 (en) |
CA (1) | CA2670276A1 (en) |
IL (1) | IL198856A0 (en) |
MX (1) | MX2009005351A (en) |
WO (1) | WO2008063165A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI433674B (en) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | Cyclopamine analogs |
US7990394B2 (en) | 2007-05-25 | 2011-08-02 | Google Inc. | Viewing and navigating within panoramic images, and applications thereof |
JP6141015B2 (en) | 2009-08-05 | 2017-06-07 | インフィニティ ファーマスーティカルズ、インク. | Enzymatic transamination of cyclopamine analogues. |
US9394313B2 (en) | 2010-09-14 | 2016-07-19 | Infinity Pharmaceuticals, Inc. | Transfer hydrogenation of cyclopamine analogs |
WO2016196928A1 (en) | 2015-06-04 | 2016-12-08 | PellePharm, Inc. | Topical formulations for delivery of hedgehog inhibitor compounds and use thereof |
US10217283B2 (en) | 2015-12-17 | 2019-02-26 | Google Llc | Navigation through multidimensional images spaces |
US10245091B2 (en) | 2015-12-30 | 2019-04-02 | Exsomed Holding Company, Llc | Dip fusion spike screw |
CN107281206A (en) * | 2016-03-30 | 2017-10-24 | 南京惠宝生物医药有限公司 | Black cohosh root glycosides is preparing the application in preventing and treating senile dementia medicine |
KR102120376B1 (en) * | 2018-05-28 | 2020-06-09 | 한국과학기술연구원 | Composition for preventing and/or treating a degenerative brain disease comprising as an active ingredient an extract of Cimicifuga dahurica, a fraction thereof, or a compound derived from Cimicifuga dahurica |
CN109528738A (en) * | 2018-12-24 | 2019-03-29 | 陕西师范大学 | Glycyrrhizic acid promotes the application of Remyelination inhibition neuroinflamation drug in preparation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030060425A1 (en) * | 1998-11-24 | 2003-03-27 | Ahlem Clarence N. | Immune modulation method using steroid compounds |
GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
CA2479249A1 (en) * | 2002-03-15 | 2003-09-25 | Samaritan Pharmaceuticals, Inc. | Neuroprotective spirostenol pharmaceutical compositions |
KR20080036552A (en) * | 2005-05-17 | 2008-04-28 | 사토리 파마슈티컬즈, 인코포레이티드 | Compounds useful for treating neurodegenerative disorders |
-
2006
- 2006-11-20 CA CA002670276A patent/CA2670276A1/en not_active Abandoned
- 2006-11-20 CN CNA2006800568742A patent/CN101610673A/en active Pending
- 2006-11-20 WO PCT/US2006/044880 patent/WO2008063165A1/en active Application Filing
- 2006-11-20 MX MX2009005351A patent/MX2009005351A/en not_active Application Discontinuation
- 2006-11-20 AU AU2006350960A patent/AU2006350960B2/en not_active Expired - Fee Related
- 2006-11-20 BR BRPI0622138-6A patent/BRPI0622138A2/en not_active IP Right Cessation
- 2006-11-20 EP EP06838050A patent/EP2073637A4/en not_active Withdrawn
- 2006-11-20 JP JP2009538376A patent/JP2010510309A/en active Pending
- 2006-11-20 KR KR1020097012727A patent/KR20090087075A/en not_active Application Discontinuation
-
2009
- 2009-05-20 IL IL198856A patent/IL198856A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2009005351A (en) | 2009-06-08 |
BRPI0622138A2 (en) | 2011-12-27 |
AU2006350960A1 (en) | 2008-05-29 |
AU2006350960B2 (en) | 2013-09-12 |
EP2073637A1 (en) | 2009-07-01 |
JP2010510309A (en) | 2010-04-02 |
WO2008063165A1 (en) | 2008-05-29 |
KR20090087075A (en) | 2009-08-14 |
CN101610673A (en) | 2009-12-23 |
CA2670276A1 (en) | 2008-05-29 |
EP2073637A4 (en) | 2011-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1225620A1 (en) | Complement inhibition for improved nerve regeneration | |
EP2083857A4 (en) | Methods for treating mica-related disorders | |
IL198856A0 (en) | Compounds useful for treating neurodegenerative disorders | |
IL194739A0 (en) | Dihydrothienopyrimidine for treating inflammatory disorders | |
AP2009004746A0 (en) | Process for prepaiIrng diaminophenothiazinium compounds | |
ZA200809528B (en) | Treatment for depressive disorders | |
AU2007288337A8 (en) | Compounds for treating proliferative disorders | |
IL192692A0 (en) | Compounds for the treatment of inflammatory disorders | |
IL198851A0 (en) | Methods for treating hypercholesterolemia | |
ZA200900734B (en) | Combination treatment for metabolic disorders | |
IL184456A0 (en) | Dosage form for treating gastrointestinal disorders | |
IL209895A0 (en) | Compounds for treating beta-amyloidoses | |
ZA200809527B (en) | Treatment for depressive disorders | |
IL187439A0 (en) | Compounds useful for treating neurodegenerative disorders | |
PL1993589T3 (en) | Treatments for neurological disorders | |
IL188729A0 (en) | Carbamate compounds for use in treating neurodegenerative disorders | |
PL1841433T3 (en) | Composition for treating central nervous system disorders | |
EP2331097A4 (en) | Methods for treating cns disorders | |
IL194373A0 (en) | Methods for treating kidney disorders | |
ZA200901672B (en) | Compounds for treating proliferative disorders | |
IL207906A0 (en) | Treatment for ocular-related disorders | |
IL188127A0 (en) | Methods for treating demyelination disorders | |
ZA200807678B (en) | Meridamycin analogues for the treatment of neurodegenerative disorders | |
ZA200903242B (en) | Treatment for multiple myeloma | |
AP2010005225A0 (en) | Process for treating sulphatecontaining effluent |